Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependence

Psychiatry and Clinical Neurosciences

Volumn 63, Issue 3, 2009, Pages 417-422

  Okahisa, Yuko ^a   Ujike, Hiroshi ^a,b   Kotaka, Tatsuya ^a   Morita, Yukitaka ^a   Kodama, Masafumi ^a   Inada, Toshiya ^b,c   Yamada, Mitsuhiko ^b,d   Iwata, Nakao ^b,e   Iyo, Masaomi ^b,f   Sora, Ichiro ^b,g   Ozaki, Norio ^b,h   Kuroda, Shigetoshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Japan Genetics Initiative for Drug Abuse ^*  (Japan)

^c SEIWA HOSPITAL   (Japan)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^e FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f CHIBA UNIVERSITY   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Case control association; Methamphetamine; Neuropeptide Y; Neuropeptide Y receptor type Y1; Substance abuse

Indexed keywords

METHAMPHETAMINE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR;

ADULT; ARTICLE; BRAIN; DRUG DEPENDENCE; ENDOGENOUS PSYCHOSIS; FEMALE; GENE; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPEPTIDE Y GENE; NEUROPEPTIDE Y RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMPHETAMINE-RELATED DISORDERS; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; METHAMPHETAMINE; NEUROPEPTIDE Y; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NEUROPEPTIDE Y;

EID: 65649128619     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2009.01961.x     Document Type: Article

References (33)

1. Adrian TE, Allen JM, Bloom SR et al. Neuropeptide y distribution in human brain. Nature 1983 306 : 584 586. (Pubitemid 14203823)
2. Gray TS, Morley JE. Neuropeptide Y: Anatomical distribution and possible function in mammalian nervous system. Life Sci. 1986 38 : 389 401. (Pubitemid 16163417)
3. Frederiksen SO, Ekman R, Gottfries CG, Widerlov E, Jonsson S. Reduced concentrations of galanin, arginine vasopressin, neuropeptide Y and peptide YY in the temporal cortex but not in the hypothalamus of brains from schizophrenics. Acta Psychiatr. Scand. 1991 83 : 273 277.
4. Gabriel SM, Davidson M, Haroutunian V et al. Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. Biol. Psychiatry 1996 39 : 82 91. (Pubitemid 26045295)
5. Kuromitsu J, Yokoi A, Kawai T et al. Reduced neuropeptide Y mRNA levels in the frontal cortex of people with schizophrenia and bipolar disorder. Brain Res. Gene Exp. Patterns 2001 1 : 17 21. (Pubitemid 33634190)
6. Sakai K, Maeda K, Chihara K, Kaneda H. Increases in cortical neuropeptide Y and somatostatin concentrations following haloperidol-depot treatment in rats. Neuropeptides 1995 29 : 157 161.
7. Smialowska M, Obuchowicz E, Turchan J, Herman ZS, Przewtocki R. Clonidine administration increases neuropeptide Y immunoreactivity and neuropeptide Y mRNA in the rat cerebral cortex neurons. Neuropeptides 1997 31 : 203 207. (Pubitemid 27297772)
8. Midgley LP, Bush LG, Gibb JW, Hanson GR. Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen. Brain Res. 1992 593 : 89 96.
9. Wahlestedt C, Karoum F, Jaskiw G et al. Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex. Proc. Natl Acad. Sci. USA 1991 88 : 2078 2082. (Pubitemid 21916357)
10. Ehlers CL, Li TK, Lumeng L et al. Neuropeptide Y levels in ethanol-naive alcohol-preferring and non-preferring rats and in Wistar rats after ethanol exposure. Alcohol. Clin. Exp. Res. 1998 22 : 1778 1782. (Pubitemid 28536170)
11. Badia-Elder NE, Stewart RB, Powrozek TA, Roy KF, Murphy JM, Li TK. Effect of neuropeptide Y (NPY) on oral ethanol intake in Wistar, alcohol-preferring (P), and -nonpreferring (NP) rats. Alcohol. Clin. Exp. Res. 2001 25 : 386 390. (Pubitemid 32221818)
12. Thiele TE, Marsh DJ, Ste Marie L, Bernstein IL, Palmiter RD. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 1998 396 : 366 369. (Pubitemid 28557396)
13. Itokawa M, Arai M, Kato S et al. Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neurosci. Lett. 2003 347 : 202 204. (Pubitemid 37271952)
14. Michel MC, Beck-Sickinger A, Cox H et al. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol. Rev. 1998 50 : 143 150. (Pubitemid 28158845)
15. Heilig M. Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding. Regul. Pept. 1995 59 : 201 205.
16. Thiele TE, Koh MT, Pedrazzini T. Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. J. Neurosci. 2002 22 : RC208.
17. Thiele TE, Badia-Elder NE. A role for neuropeptide Y in alcohol intake control: Evidence from human and animal research. Physiol. Behav. 2003 79 : 95 101. (Pubitemid 36734833)
18. Vawter MP, Ferran E, Galke B, Cooper K, Bunney WE, Byerley W. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr. Res. 2004 67 : 41 52. (Pubitemid 38117090)
19. Caberlotto L, Hurd YL. Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior. Neuropsychopharmacology 2001 25 : 91 97. (Pubitemid 32493825)
20. Ito H, Morita T, Suehiro T et al. Neuropeptide Y Y1 receptor polymorphism as a prognostic predictor in Japanese patients with IgA nephropathy. Clin. Nephrol. 1999 51 : 272 279. (Pubitemid 29219294)
21. Ujike H, Harano M, Inada T et al. Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosis. Pharmacogenomics J. 2003 3 : 242 247. (Pubitemid 37160980)
22. Ujike H, Sato M. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann. N. Y. Acad. Sci. 2004 1025 : 279 287. (Pubitemid 39643873)
23. Buckland PR, Hoogendoorn B, Guy CA et al. A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity. Biochim. Biophys. Acta 2004 1690 : 238 249. (Pubitemid 39423619)
24. Karvonen MK, Pesonen U, Koulu M et al. Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat. Med. 1998 4 : 1434 1437. (Pubitemid 28553469)
25. Lappalainen J, Kranzler HR, Malison R et al. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch. Gen. Psychiatry 2002 59 : 825 831.
26. Drube J, Kawamura N, Nakamira A, Ando T, Komaki G, Inada T. No leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y in Japanese population or Japanese with alcoholism. Psychiatr. Genet. 2001 11 : 53 55. (Pubitemid 32499864)
27. Makino K, Kataoka Y, Hirakawa Y, Ikeda A, Yamauchi A, Oishi AR. A leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y was not identified in the Japanese population. J. Clin. Pharm. Ther. 2001 26 : 201 203. (Pubitemid 32592551)
28. Ding B, Bertilsson L, Wahlestedt C. The single nucleotide polymorphism T1128C in the signal peptide of neuropeptide Y (NPY) was not identified in a Korean population. J. Clin. Pharm. Ther. 2002 27 : 211 212. (Pubitemid 34748146)
29. Mottagui-Tabar S, Prince JA, Wahlestedt C, Zhu G, Goldman D, Heilig M. A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence. Alcohol. Clin. Exp. Res. 2005 29 : 702 707. (Pubitemid 40686538)
30. Kask A, Rago L, Harro J. Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: Antagonism with diazepam. Eur. J. Pharmacol. 1996 317 : R3 R4. (Pubitemid 27014053)
31. Kask A, Rago L, Harro J. Anxiogenic-like effect of the NPY Y1 receptor antagonist BIBP3226 administered into the dorsal periaqueductal gray matter in rats. Regul. Pept. 1998 75-76 : 255 262. (Pubitemid 28477535)
32. Kask A, Harro J. Inhibition of amphetamine- and apomorphine-induced behavioural effects by neuropeptide Y Y(1) receptor antagonist BIBO 3304. Neuropharmacology 2000 39 : 1292 1302. (Pubitemid 30173193)
33. Thiele TE, Sparta DR, Hayes DM, Fee JR. A role for neuropeptide Y in neurobiological responses to ethanol and drug abuse. Neuropeptides 2004 38 : 235 243. (Pubitemid 39158862)